Gilbert & Cook Inc. Has $909,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Gilbert & Cook Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 238.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,555 shares of the healthcare conglomerate's stock after buying an additional 1,095 shares during the quarter. Gilbert & Cook Inc.'s holdings in UnitedHealth Group were worth $909,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. International Assets Investment Management LLC boosted its holdings in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Swedbank AB purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at approximately $1,117,462,000. Lone Pine Capital LLC purchased a new position in UnitedHealth Group during the second quarter worth about $480,903,000. Dimensional Fund Advisors LP lifted its stake in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. Finally, Baillie Gifford & Co. increased its position in shares of UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate's stock worth $455,281,000 after acquiring an additional 821,050 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.2 %

Shares of NYSE:UNH traded down $0.92 during trading on Friday, reaching $592.23. 3,423,919 shares of the company traded hands, compared to its average volume of 3,119,612. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a fifty day simple moving average of $582.84 and a 200 day simple moving average of $549.52. The firm has a market cap of $545.02 billion, a P/E ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group's revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's payout ratio is 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 16th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. HSBC downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, October 17th. Finally, Barclays lowered their price target on UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.